GRCE
Financials
- Market Capitalization 40.03 M
- Employee 5
- Founded 2002
- CEO N/A
- Website www.gracetx.com
- Headquarter Delaware, United States
- FIGI BBG001NMDXS6
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4363 |  PDSB PDS Biotechnology Corporation - Common Stock | 0.75 USD | 0.00% | -9.64% | -24.24% | -34.78% | 41.86 M USD | ||
| 4373 |  ACTU Actuate Therapeutics, Inc. - Common stock | 1.73 USD | +15.33% | +16.89% | -15.61% | -57.60% | 41.39 M USD | ||
| 4393 |  RNXT RenovoRx, Inc. - Common Stock | 0.85 USD | -6.59% | -7.61% | -3.41% | -35.61% | 38.33 M USD | ||
| 4394 |  NNVC NanoViricides, Inc. Common Stock | 1.77 USD | +7.27% | +19.59% | +24.65% | +75.23% | 38.32 M USD |
Frequently asked questions about Grace Therapeutics, Inc. - Common Stock
What is the Grace Therapeutics, Inc. - Common Stock stock price today?
The current price of Grace Therapeutics, Inc. - Common Stock (GRCE) is 2.46. Over the past 24 hours, the stock has changed by +1.23%. Follow the GRCE chart for real-time price dynamics.
What is the stock ticker of Grace Therapeutics, Inc. - Common Stock?
Grace Therapeutics, Inc. - Common Stock trades under the ticker GRCE. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Grace Therapeutics, Inc. - Common Stock stock going up?
GRCE has changed by -1.60% over the last week, +10.81% over the last month, and -38.19% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Grace Therapeutics, Inc. - Common Stock net income for the last quarter?
Grace Therapeutics, Inc. - Common Stock reported net income of -1.18 M for the last quarter. The previous quarter showed -2.31 M, which means net income changed by +49.11%.
How many employees does Grace Therapeutics, Inc. - Common Stock have?
As of the latest available data, Grace Therapeutics, Inc. - Common Stock has 5 employees. Workforce size can provide additional context about the company's scale and operations.
What is Grace Therapeutics, Inc. - Common Stock EBITDA?
Grace Therapeutics, Inc. - Common Stock EBITDA is -2.59 M, and its EBITDA margin is 37.06 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Grace Therapeutics, Inc. - Common Stock stock?
You can buy Grace Therapeutics, Inc. - Common Stock (GRCE) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Grace Therapeutics, Inc. - Common Stock stock?
Investing in Grace Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the GRCE chart and related analysis on metatrader.com as part of your research.